Top News

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma |New England Journal of Medicine

A powerful gene-editing technology is the biggest game changer to hit biology since PCR. But with its huge potential come pressing concerns |Nature

An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression |Cancer Gene Therapy


BVAPS 2016 – Biomarkers of Vaccine/Adjuvant Potency & Safety
Crowne Plaza Porto, Porto, Portugal
6-8 April 2016

MVW 2016 – Malaria Vaccines for the World
Leiden, The Netherlands
2-4 May 2016

MVAF 2016 – Modern Vaccines Adjuvants Formulation
Copenhagen, Denmark
18-20 May 2016

More Events

Social Media